Compare IOVA & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOVA | INOD |
|---|---|---|
| Founded | 2007 | 1988 |
| Country | United States | United States |
| Employees | N/A | 3000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2008 | 1996 |
| Metric | IOVA | INOD |
|---|---|---|
| Price | $3.41 | $44.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | $9.00 | ★ $100.00 |
| AVG Volume (30 Days) | ★ 14.0M | 835.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.84 | 3.37 |
| EPS | N/A | ★ 0.92 |
| Revenue | N/A | ★ $86,775,000.00 |
| Revenue This Year | $47.74 | $38.42 |
| Revenue Next Year | $40.31 | $27.03 |
| P/E Ratio | ★ N/A | $46.20 |
| Revenue Growth | N/A | ★ 9.84 |
| 52 Week Low | $1.64 | $31.95 |
| 52 Week High | $5.63 | $93.82 |
| Indicator | IOVA | INOD |
|---|---|---|
| Relative Strength Index (RSI) | 44.83 | 53.76 |
| Support Level | $2.03 | $41.31 |
| Resistance Level | $4.33 | $47.79 |
| Average True Range (ATR) | 0.20 | 2.57 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 19.29 | 49.14 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.